Atlas Trials

A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT03818542 · TERMINATED

Trial details

NCT number
NCT03818542
Sponsor
AbbVie
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2020-01-22
Primary completion
2020-09-23
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.